Merck Announces FDA Acceptance of New Drug Application for Suvorexant, an Investigational Insomnia Medicine

Merck Announces FDA Acceptance of New Drug Application for Suvorexant, an Investigational Insomnia Medicine

document.addEventListener("googletagEvent", function() { googletag.cmd.push(function() { googletag.display('ad-slot_1__mobile'); }); }); Thursday, November 8, 2012
Read more on